(NASDAQ: IVF) Invo Fertility's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 14.27%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 41.04%.
Invo Fertility's earnings in 2025 is -$28,193,234.On average, 2 Wall Street analysts forecast IVF's earnings for 2025 to be -$14,674,132, with the lowest IVF earnings forecast at -$14,238,266, and the highest IVF earnings forecast at -$15,255,285. On average, 2 Wall Street analysts forecast IVF's earnings for 2026 to be -$12,955,540, with the lowest IVF earnings forecast at -$12,570,722, and the highest IVF earnings forecast at -$13,468,630.
In 2027, IVF is forecast to generate -$24,324,687 in earnings, with the lowest earnings forecast at -$23,602,171 and the highest earnings forecast at -$25,288,041.